Large deletion at the CDC73 gene locus and search for predictive markers of the presence of a CDC73 genetic lesion
The Hyperparathyroidism with Jaw-Tumours syndrome is caused by mutations of the gene: it has been suggested that early onset of the disease and high Ca levels may predict the presence of a mutation. We searched for large deletions at the locus in patients with: HPT-JT (nr 2), atypical adenoma (nr 7)...
Saved in:
Published in | Oncotarget Vol. 9; no. 29; pp. 20721 - 20733 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Impact Journals LLC
17.04.2018
|
Subjects | |
Online Access | Get full text |
ISSN | 1949-2553 1949-2553 |
DOI | 10.18632/oncotarget.25067 |
Cover
Abstract | The Hyperparathyroidism with Jaw-Tumours syndrome is caused by mutations of the
gene: it has been suggested that early onset of the disease and high Ca
levels may predict the presence of a
mutation. We searched for large deletions at the
locus in patients with: HPT-JT (nr 2), atypical adenoma (nr 7) or sporadic parathyroid carcinoma (nr 11) with a specific MLPA and qRT-PCR assays applied on DNA extracted from whole blood. A Medline search in database for all the papers reporting a
gene mutation, clinical/histological diagnosis, age at onset, Ca
, PTH levels for familial/sporadic cases was conducted with the aim to possibly identify biochemical/clinical markers predictive, in first diagnosis, of the presence of a
gene mutation. A novel genomic deletion of the first 10 exons of the
gene was found in a 3-generation HPT-JT family, confirmed by SNP array analysis. A classification tree built on the published data, showed the highest probability of having a
mutation in subjects with age at the onset < 41.5 years (44/47 subjects, 93.6%, had the mutation). Whereas the lowest probability was found in subjects with age at the onset ≥ 41.5 years and Ca
levels <13.96 mg/dL (7/20 subjects, 35.0%, had the mutation, odds ratio = 27.1,
< 0.001). We report a novel large genomic CDC73 gene deletion identified in an Italian HPT-JT family. Age at onset < 41.5 ys and Ca
> 13.96 mg/dL are predictive for the presence of a CDC73 genetic lesion. |
---|---|
AbstractList | The Hyperparathyroidism with Jaw-Tumours syndrome is caused by mutations of the CDC73 gene: it has been suggested that early onset of the disease and high Ca2+ levels may predict the presence of a CDC73 mutation. We searched for large deletions at the CDC73 locus in patients with: HPT-JT (nr 2), atypical adenoma (nr 7) or sporadic parathyroid carcinoma (nr 11) with a specific MLPA and qRT-PCR assays applied on DNA extracted from whole blood. A Medline search in database for all the papers reporting a CDC73 gene mutation, clinical/histological diagnosis, age at onset, Ca2+, PTH levels for familial/sporadic cases was conducted with the aim to possibly identify biochemical/clinical markers predictive, in first diagnosis, of the presence of a CDC73 gene mutation. A novel genomic deletion of the first 10 exons of the CDC73 gene was found in a 3-generation HPT-JT family, confirmed by SNP array analysis. A classification tree built on the published data, showed the highest probability of having a CDC73 mutation in subjects with age at the onset < 41.5 years (44/47 subjects, 93.6%, had the mutation). Whereas the lowest probability was found in subjects with age at the onset ≥ 41.5 years and Ca2+ levels <13.96 mg/dL (7/20 subjects, 35.0%, had the mutation, odds ratio = 27.1, p < 0.001). We report a novel large genomic CDC73 gene deletion identified in an Italian HPT-JT family. Age at onset < 41.5 ys and Ca2+ > 13.96 mg/dL are predictive for the presence of a CDC73 genetic lesion.The Hyperparathyroidism with Jaw-Tumours syndrome is caused by mutations of the CDC73 gene: it has been suggested that early onset of the disease and high Ca2+ levels may predict the presence of a CDC73 mutation. We searched for large deletions at the CDC73 locus in patients with: HPT-JT (nr 2), atypical adenoma (nr 7) or sporadic parathyroid carcinoma (nr 11) with a specific MLPA and qRT-PCR assays applied on DNA extracted from whole blood. A Medline search in database for all the papers reporting a CDC73 gene mutation, clinical/histological diagnosis, age at onset, Ca2+, PTH levels for familial/sporadic cases was conducted with the aim to possibly identify biochemical/clinical markers predictive, in first diagnosis, of the presence of a CDC73 gene mutation. A novel genomic deletion of the first 10 exons of the CDC73 gene was found in a 3-generation HPT-JT family, confirmed by SNP array analysis. A classification tree built on the published data, showed the highest probability of having a CDC73 mutation in subjects with age at the onset < 41.5 years (44/47 subjects, 93.6%, had the mutation). Whereas the lowest probability was found in subjects with age at the onset ≥ 41.5 years and Ca2+ levels <13.96 mg/dL (7/20 subjects, 35.0%, had the mutation, odds ratio = 27.1, p < 0.001). We report a novel large genomic CDC73 gene deletion identified in an Italian HPT-JT family. Age at onset < 41.5 ys and Ca2+ > 13.96 mg/dL are predictive for the presence of a CDC73 genetic lesion. The Hyperparathyroidism with Jaw-Tumours syndrome is caused by mutations of the CDC73 gene: it has been suggested that early onset of the disease and high Ca 2+ levels may predict the presence of a CDC73 mutation. We searched for large deletions at the CDC73 locus in patients with: HPT-JT (nr 2), atypical adenoma (nr 7) or sporadic parathyroid carcinoma (nr 11) with a specific MLPA and qRT-PCR assays applied on DNA extracted from whole blood. A Medline search in database for all the papers reporting a CDC73 gene mutation, clinical/histological diagnosis, age at onset, Ca 2+ , PTH levels for familial/sporadic cases was conducted with the aim to possibly identify biochemical/clinical markers predictive, in first diagnosis, of the presence of a CDC73 gene mutation. A novel genomic deletion of the first 10 exons of the CDC73 gene was found in a 3-generation HPT-JT family, confirmed by SNP array analysis. A classification tree built on the published data, showed the highest probability of having a CDC73 mutation in subjects with age at the onset < 41.5 years (44/47 subjects, 93.6%, had the mutation). Whereas the lowest probability was found in subjects with age at the onset ≥ 41.5 years and Ca 2+ levels <13.96 mg/dL (7/20 subjects, 35.0%, had the mutation, odds ratio = 27.1, p < 0.001). We report a novel large genomic CDC73 gene deletion identified in an Italian HPT-JT family. Age at onset < 41.5 ys and Ca 2+ > 13.96 mg/dL are predictive for the presence of a CDC73 genetic lesion. The Hyperparathyroidism with Jaw-Tumours syndrome is caused by mutations of the gene: it has been suggested that early onset of the disease and high Ca levels may predict the presence of a mutation. We searched for large deletions at the locus in patients with: HPT-JT (nr 2), atypical adenoma (nr 7) or sporadic parathyroid carcinoma (nr 11) with a specific MLPA and qRT-PCR assays applied on DNA extracted from whole blood. A Medline search in database for all the papers reporting a gene mutation, clinical/histological diagnosis, age at onset, Ca , PTH levels for familial/sporadic cases was conducted with the aim to possibly identify biochemical/clinical markers predictive, in first diagnosis, of the presence of a gene mutation. A novel genomic deletion of the first 10 exons of the gene was found in a 3-generation HPT-JT family, confirmed by SNP array analysis. A classification tree built on the published data, showed the highest probability of having a mutation in subjects with age at the onset < 41.5 years (44/47 subjects, 93.6%, had the mutation). Whereas the lowest probability was found in subjects with age at the onset ≥ 41.5 years and Ca levels <13.96 mg/dL (7/20 subjects, 35.0%, had the mutation, odds ratio = 27.1, < 0.001). We report a novel large genomic CDC73 gene deletion identified in an Italian HPT-JT family. Age at onset < 41.5 ys and Ca > 13.96 mg/dL are predictive for the presence of a CDC73 genetic lesion. |
Author | Repaci, Andrea Cinque, Luigia Chiofalo, Maria Grazia Turchetti, Daniela Pezzullo, Luciano Franco, Renato Graziano, Paolo Fontana, Andrea Palumbo, Orazio de Martino, Danilo Copetti, Massimiliano Muscarella, Lucia Anna Baorda, Filomena la Torre, Annamaria Guarnieri, Vito Pagotto, Uberto Scillitani, Alfredo Losito, Nunzia Simona |
Author_xml | – sequence: 1 givenname: Lucia Anna surname: Muscarella fullname: Muscarella, Lucia Anna organization: Laboratory of Oncology, IRCCS Casa Sollievo della Sofferenza Hospital, San Giovanni Rotondo 71013, Italy – sequence: 2 givenname: Daniela surname: Turchetti fullname: Turchetti, Daniela organization: Medical Genetics, Sant’Orsola Malpighi Hospital, University of Bologna, Bologna 40138, Italy – sequence: 3 givenname: Andrea surname: Fontana fullname: Fontana, Andrea organization: Unit of Biostatistics, IRCCS Casa Sollievo della Sofferenza Hospital, San Giovanni Rotondo 71013, Italy – sequence: 4 givenname: Filomena surname: Baorda fullname: Baorda, Filomena organization: Medical Genetics, IRCCS Casa Sollievo della Sofferenza Hospital, San Giovanni Rotondo 71013, Italy – sequence: 5 givenname: Orazio surname: Palumbo fullname: Palumbo, Orazio organization: Medical Genetics, IRCCS Casa Sollievo della Sofferenza Hospital, San Giovanni Rotondo 71013, Italy – sequence: 6 givenname: Annamaria surname: la Torre fullname: la Torre, Annamaria organization: Laboratory of Oncology, IRCCS Casa Sollievo della Sofferenza Hospital, San Giovanni Rotondo 71013, Italy, ISBReMIT, Institute for Stem-cell Biology, Regenerative Medicine and Innovative Therapies, IRCCS Casa Sollievo della Sofferenza Hospital, San Giovanni Rotondo 71013, Italy – sequence: 7 givenname: Danilo surname: de Martino fullname: de Martino, Danilo organization: Thoracic Surgery, IRCCS Casa Sollievo della Sofferenza Hospital, San Giovanni Rotondo 71013, Italy – sequence: 8 givenname: Renato surname: Franco fullname: Franco, Renato organization: Pathology , Istituto Nazionale Tumori, Fondazione “G. Pascale”, Napoli 80131, Italy – sequence: 9 givenname: Nunzia Simona surname: Losito fullname: Losito, Nunzia Simona organization: Pathology , Istituto Nazionale Tumori, Fondazione “G. Pascale”, Napoli 80131, Italy – sequence: 10 givenname: Andrea surname: Repaci fullname: Repaci, Andrea organization: Endocrinology, Sant’Orsola Malpighi Hospital, University of Bologna, Bologna 40138, Italy – sequence: 11 givenname: Uberto surname: Pagotto fullname: Pagotto, Uberto organization: Endocrinology, Sant’Orsola Malpighi Hospital, University of Bologna, Bologna 40138, Italy – sequence: 12 givenname: Luigia surname: Cinque fullname: Cinque, Luigia organization: Medical Genetics, IRCCS Casa Sollievo della Sofferenza Hospital, San Giovanni Rotondo 71013, Italy – sequence: 13 givenname: Massimiliano surname: Copetti fullname: Copetti, Massimiliano organization: Unit of Biostatistics, IRCCS Casa Sollievo della Sofferenza Hospital, San Giovanni Rotondo 71013, Italy – sequence: 14 givenname: Maria Grazia surname: Chiofalo fullname: Chiofalo, Maria Grazia organization: Thyroid and Parathyroid Surgery Unit, Istituto Nazionale Tumori, Fondazione “G. Pascale”, Napoli 80131, Italy – sequence: 15 givenname: Luciano surname: Pezzullo fullname: Pezzullo, Luciano organization: Thyroid and Parathyroid Surgery Unit, Istituto Nazionale Tumori, Fondazione “G. Pascale”, Napoli 80131, Italy – sequence: 16 givenname: Paolo surname: Graziano fullname: Graziano, Paolo organization: Pathology, IRCCS Casa Sollievo della Sofferenza Hospital, San Giovanni Rotondo 71013, Italy – sequence: 17 givenname: Alfredo surname: Scillitani fullname: Scillitani, Alfredo organization: Endocrinology, IRCCS Casa Sollievo della Sofferenza Hospital, San Giovanni Rotondo 71013, Italy – sequence: 18 givenname: Vito surname: Guarnieri fullname: Guarnieri, Vito organization: Medical Genetics, IRCCS Casa Sollievo della Sofferenza Hospital, San Giovanni Rotondo 71013, Italy |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29755684$$D View this record in MEDLINE/PubMed |
BookMark | eNp9UUtvGyEQRpWrxnn8gF4ijr3YYdll2b1UqpynZKmX5IzYYdYmWYML2FL-fbDzqNNDucBovscw3zEZOe-QkO8FmxZNXfIL78AnHRaYplywWn4h46Kt2gkXohwdvI_IWYyPLB9RyYa338gRb6UQdVONSZjvFKjBAZP1jupE0xLp7HImS7pAh3TwsIlUO0Mj6gBL2vtA1wGNhWS3SFc6PGGI1Pd7Zu5EdIC7Wh_oJAt0wJg9TsnXXg8Rz97uE_JwfXU_u53Mf9_czX7NJ1AWlZyAMQ3rOPLOdKWWRncF66qmzv8AAUXNAWrRgOhE3xussdU9NwIMZx3Kqq_KE_LzVXe96VZoAF0KelDrYPPIz8prqz53nF2qhd8q0VZ5bWUW-PEmEPyfDcakVjYCDoN26DdRcVY2knHO2ww9P_T6MHlfdAYUrwAIPsaA_QekYGqfp_qbp9rnmTnyHw7YpHcx5XHt8B_mC_qHqmo |
CitedBy_id | crossref_primary_10_1002_jbmr_3650 crossref_primary_10_1155_2020_2080797 crossref_primary_10_3390_ijms22042016 crossref_primary_10_1007_s12020_021_02917_5 crossref_primary_10_2478_ebtj_2020_0008 crossref_primary_10_3390_endocrines4010018 crossref_primary_10_1155_2020_9298147 crossref_primary_10_3390_ijms25042301 crossref_primary_10_1016_j_beem_2018_11_002 crossref_primary_10_1111_ijlh_13569 crossref_primary_10_3390_cells10112920 |
Cites_doi | 10.1097/MPH.0000000000000443 10.1210/jc.2012-2789 10.1111/cen.12461 10.1128/MCB.25.2.612-620.2005 10.1007/s12022-008-9050-2 10.1128/MCB.25.12.5052-5060.2005 10.1038/ng1048 10.1002/gcc.20911 10.1111/j.1365-2265.2011.04184.x 10.1210/jc.2014-1481 10.1002/humu.21188 10.1056/NEJMoa031237 10.1038/ncomms6433 |
ContentType | Journal Article |
Copyright | Copyright: © 2018 Muscarella et al. 2018 |
Copyright_xml | – notice: Copyright: © 2018 Muscarella et al. 2018 |
DBID | AAYXX CITATION NPM 7X8 5PM |
DOI | 10.18632/oncotarget.25067 |
DatabaseName | CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic PubMed |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
EISSN | 1949-2553 |
EndPage | 20733 |
ExternalDocumentID | PMC5945533 29755684 10_18632_oncotarget_25067 |
Genre | Journal Article |
GroupedDBID | --- 53G AAYXX ADBBV ADRAZ AENEX ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL CITATION DIK FRJ GX1 HYE KQ8 M48 OK1 PGMZT RPM NPM 7X8 5PM |
ID | FETCH-LOGICAL-c3147-cdd80b2e2bdb3a7dab10b486000c5c162cc658c5b5ffde6e9af2d5cd20be74f43 |
IEDL.DBID | M48 |
ISSN | 1949-2553 |
IngestDate | Thu Aug 21 18:34:44 EDT 2025 Fri Jul 11 08:48:10 EDT 2025 Thu Apr 03 07:02:15 EDT 2025 Thu Apr 24 23:03:35 EDT 2025 Tue Jul 01 02:03:13 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | true |
Issue | 29 |
Keywords | HPT-JT large genomic deletion early onset CDC73 |
Language | English |
License | This is an open-access article distributed under the terms of the Creative Commons Attribution License 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c3147-cdd80b2e2bdb3a7dab10b486000c5c162cc658c5b5ffde6e9af2d5cd20be74f43 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 These authors contributed equally to this work |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.18632/oncotarget.25067 |
PMID | 29755684 |
PQID | 2038702229 |
PQPubID | 23479 |
PageCount | 13 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_5945533 proquest_miscellaneous_2038702229 pubmed_primary_29755684 crossref_primary_10_18632_oncotarget_25067 crossref_citationtrail_10_18632_oncotarget_25067 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2018-04-17 2018-Apr-17 20180417 |
PublicationDateYYYYMMDD | 2018-04-17 |
PublicationDate_xml | – month: 04 year: 2018 text: 2018-04-17 day: 17 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Oncotarget |
PublicationTitleAlternate | Oncotarget |
PublicationYear | 2018 |
Publisher | Impact Journals LLC |
Publisher_xml | – name: Impact Journals LLC |
References | Corbetta (20) 2010; 35 Beckers (2) 2015; 2 23 Chanson (16) 2013; 98 Xing (18) 2014; 81 Cavaco (21) 2017; 6 24 Jones (8) 2002; 32 Diaz-Thomas (19) 2016; 38 Shaw (4) 1999; 3 Arnold (9) 2003; 349 Krek (10) 2005; 25 Thakker (13) 2010; 31 Mete (7) 2012; 4 Robledo (14) 2011; 50 Schalin-Jäntti (17) 2014; 99 Thakker (1) 2017; 12 Delellis (3) 2008; 4 Benvenga (5) 2012; 3 Cavaco (15) 2012; 76 Väisänen (22) 2017; 7 Baldari (6) 2017; 1 Meyerson (11) 2005; 25 Yoo (12) 2014; 5 |
References_xml | – volume: 38 start-page: 32 year: 2016 ident: 19 article-title: Parathyroid Cancer in the Pediatric Patient publication-title: Journal of Pediatric Hematology/Oncology doi: 10.1097/MPH.0000000000000443 – volume: 98 start-page: E403 year: 2013 ident: 16 article-title: Frequent large germline HRPT2 deletions in a French National cohort of patients with primary hyperparathyroidism publication-title: Journal of Clinical Endocrinology and Metabolism doi: 10.1210/jc.2012-2789 – volume: 3 start-page: 155 year: 1999 ident: 4 article-title: Parathyroid cancer: biology and management publication-title: Surg Oncol – volume: 81 start-page: 222 year: 2014 ident: 18 article-title: Familial isolated primary hyperparathyroidism/hyperparathyroidism-jaw tumour syndrome caused by germline gross deletion or point mutations of CDC73 gene in Chinese publication-title: Clinical Endocrinology (Oxf) doi: 10.1111/cen.12461 – volume: 25 start-page: 612 year: 2005 ident: 11 article-title: The parafibromin tumor suppressor protein is part of a human Paf1 complex publication-title: Molecular and Cellular Biology doi: 10.1128/MCB.25.2.612-620.2005 – volume: 4 start-page: 221 year: 2008 ident: 3 article-title: Challenging lesions in the differential diagnosis of endocrine tumors: parathyroid carcinoma publication-title: Endocr Pathol doi: 10.1007/s12022-008-9050-2 – volume: 25 start-page: 5052 year: 2005 ident: 10 article-title: The HRPT2 tumor suppressor gene product parafibromin associates with human PAF1 and RNA polymerase II publication-title: Molecular and Cellular Biology doi: 10.1128/MCB.25.12.5052-5060.2005 – volume: 12 start-page: 1621 year: 2017 ident: 1 article-title: Molecular genetics of syndromic and non-syndromic forms of parathyroid carcinoma publication-title: Hum Mutat – volume: 32 start-page: 676 year: 2002 ident: 8 article-title: HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome publication-title: Nature Genetics doi: 10.1038/ng1048 – volume: 50 start-page: 922 year: 2011 ident: 14 article-title: Detection of the first gross CDC73 germline deletion in an HPT-JT syndrome family publication-title: Genes Chromosomes Cancer doi: 10.1002/gcc.20911 – volume: 35 start-page: 411 year: 2010 ident: 20 article-title: CDC73 mutations and parafibromin immunohistochemistry in parathyroid tumors: clinical correlations in a single-centre patient cohort publication-title: Cellular Oncology (Dordr) – volume: 76 start-page: 33 year: 2012 ident: 15 article-title: Identification of the first germline HRPT2 whole-gene deletion in a patient with primary hyperparathyroidism publication-title: Clinical Endocrinology (Oxf) doi: 10.1111/j.1365-2265.2011.04184.x – volume: 2 start-page: 169 year: 2015 ident: 2 article-title: Parathyroid carcinoma: Challenges in diagnosis and treatment publication-title: Ann Endocrinol (Paris) – volume: 99 start-page: 3044 year: 2014 ident: 17 article-title: CDC73 intragenic deletion in familial primary hyperparathyroidism associated with parathyroid carcinoma publication-title: Journal of Clinical Endocrinology and Metabolism doi: 10.1210/jc.2014-1481 – volume: 31 start-page: 295 year: 2010 ident: 13 article-title: Cell division cycle protein 73 homolog (CDC73) mutations in the hyperparathyroidism-jaw tumor syndrome (HPT-JT) and parathyroid tumors publication-title: Human Mutation doi: 10.1002/humu.21188 – volume: 1 start-page: 19 year: 2017 ident: 6 article-title: Association of parathyroid carcinoma and thyroid disorders: A clinical review publication-title: Endocrine – volume: 3 start-page: 367 year: 2012 ident: 5 article-title: Parathyroid carcinoma presenting as normocalcemic hyperparathyroidism publication-title: J Bone Miner Metab – volume: 7 start-page: 991 year: 2017 ident: 22 article-title: A nationwide study on parathyroid carcinoma publication-title: Acta Oncologica – volume: 349 start-page: 1722 year: 2003 ident: 9 article-title: Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma publication-title: New England Journal of Medicine doi: 10.1056/NEJMoa031237 – volume: 5 start-page: 5433 year: 2014 ident: 12 article-title: Cytoplasmic parafibromin/hCDC73 targets and destabilizes p53 mRNA to control p53-mediated apoptosis publication-title: Nature Communications doi: 10.1038/ncomms6433 – volume: 6 start-page: e92061 year: 2017 ident: 21 article-title: Genomic profiling reveals mutational landscape in parathyroid carcinomas publication-title: JCI Insight – ident: 24 – volume: 4 start-page: 221 year: 2012 ident: 7 article-title: Biomarkers of parathyroid carcinoma publication-title: Endocr Pathol – ident: 23 |
SSID | ssj0000547829 |
Score | 2.2711632 |
Snippet | The Hyperparathyroidism with Jaw-Tumours syndrome is caused by mutations of the
gene: it has been suggested that early onset of the disease and high Ca
levels... The Hyperparathyroidism with Jaw-Tumours syndrome is caused by mutations of the CDC73 gene: it has been suggested that early onset of the disease and high Ca2+... The Hyperparathyroidism with Jaw-Tumours syndrome is caused by mutations of the CDC73 gene: it has been suggested that early onset of the disease and high Ca... |
SourceID | pubmedcentral proquest pubmed crossref |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 20721 |
SubjectTerms | Research Paper |
Title | Large deletion at the CDC73 gene locus and search for predictive markers of the presence of a CDC73 genetic lesion |
URI | https://www.ncbi.nlm.nih.gov/pubmed/29755684 https://www.proquest.com/docview/2038702229 https://pubmed.ncbi.nlm.nih.gov/PMC5945533 |
Volume | 9 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1La9tAEF6c5NJLaUmaumnDBnIKyNFjV7s6lFLcOCbEPdXgm9gnLbiSI9vQ_vvOrGTXbkKgR6F9iG9mNd_s7M4QclmIxCouVeTB-Iatm6hg2kauMDZ13nsWbvFPvubjKbub8VmPbMpbdQAun3TtsJ7UtJkPfj38_gQL_iMueJln6XWNeQzCwekBWPRcHJAjMEw5-mKTju23qb4Z2MMixJlZEQGZzro455Oj7FuqR_Tz31OUO2Zp9Iq87Pgk_dwqwGvSc9Uxae5xAoo1bhB3qlYUeB4dfhmKjILGOAombL2kqrK0VXUK3JUuGoza4P-P_sRTO82S1j70XIRLSsbhs9oZByalc4cbbidkOrr5NhxHXXGFyGQJE5GxVsY6dam2OlPCKp3EGitSxbHhJslTY4CcGK6599blrlA-tRwEGGsnmGfZG3JY1ZV7S6jNpJPMmDS2milMuGMAfuYkl94rwfok3gBZmi7zOBbAmJfogSD25V_sy4B9n1xtuyzatBvPNb7YSKeExYERD1W5er0sUwzOo0tb9MlpK63tcHilmOcSvk7syXHbABNv77-pfnwPCbh5wUB3snf_85Fn5AVwLYmBqES8J4erZu0-AJ9Z6XNycDtLzoOu_gEWYvoX |
linkProvider | Scholars Portal |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Large+deletion+at+the+CDC73+gene+locus+and+search+for+predictive+markers+of+the+presence+of+a+CDC73+genetic+lesion&rft.jtitle=Oncotarget&rft.au=Muscarella%2C+Lucia+Anna&rft.au=Turchetti%2C+Daniela&rft.au=Fontana%2C+Andrea&rft.au=Baorda%2C+Filomena&rft.date=2018-04-17&rft.issn=1949-2553&rft.eissn=1949-2553&rft.volume=9&rft.issue=29&rft.spage=20721&rft.epage=20733&rft_id=info:doi/10.18632%2Foncotarget.25067&rft.externalDBID=n%2Fa&rft.externalDocID=10_18632_oncotarget_25067 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1949-2553&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1949-2553&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1949-2553&client=summon |